Ray Armand
Houston, TX ***41
*********@*******.***
Experience and Training
**** – 2013 Lead Hematopathologist, Applied Diagnostics and MLD
Pathology, Houston TX
Hematopathology, including interpretation of flow cytometry,
FISH, molecular tests
Surgical Pathology (Digital Image Analysis,
Immunohistochemistry)
2005 – 2007 Staff Pathologist, Midland Memorial Hospital, Midland TX
General Anatomic and Clinical Pathology
2004 – 2005 Fellowship in Hematopathology, University of Texas Health
Sciences Center, San Antonio TX
2000 – 2004 Residency in Anatomic/Clinical Pathology, University of Maryland
Medical Center, Baltimore MD
1999 – 2000 Research Fellowship in Cancer Pharmacology, Dartmouth
University, Lebanon NH
1997 – 1999 Residency in Psychiatry, University of Vermont/Fletcher-Allen
Health Care, Burlington VT
Internship in internal medicine and neurology
1993 – 1997 Analytical Chemistry, Centre Analytical Laboratories, State
College PA
1990 – 1993 Forensic Physician, Borazjan Jurisdiction, Iran (Physicians’
Public/Military Service)
Education
1983 – 1990 M.D., Tehran University of Medical Sciences, Tehran, Iran
Specialty Board Certification
American Board of Pathology
Hematopathology 9/23/2005
Anatomic and Clinical Pathology 7/26/2004
Immigration status
U.S. Citizen
1
Active State Medical Licenses, Numbers and Dates Issued
Texas L9076, 8/16/2004
Louisiana MD.204371, 1/27/2011
Oklahoma 28160, 3/18/2011
Alabama MD.30830, 3/23/2011
Arkansas E-7077, 6/10/2011
North Carolina 2012-00819, 5/4/2012
Tennessee MD49249, 1/4/2013
Extracurricular Activities
Sightseeing
Walking, swimming
Publications
1. Yeo TK, Kintner J, Armand R, Perez R, Lewis LD. Sublethal concentrations of
gemcitabine (2',2'-difluorodeoxycytidine) alter mitochondrial ultrastructure and
function without reducing mitochondrial DNA content in BxPC-3 human
pancreatic carcinoma cells. Hum Exp Toxicol. 2007 Dec;26(12):911-21.
2. Armand R, Channon JY, Kintner J, White KA, Miselis KA, Perez RP, Lewis LD.
The effects of ethidium bromide induced loss of mitochondrial DNA on
mitochondrial phenotype and ultrastructure in a human leukemia T-cell line
(MOLT-4 cells). Toxicology and Applied Pharmacology. 2004 Apr 1;196(1):68-
79.
3. Papadimitriou JC, Nikitakis N, Armand R. Immunohistochemical studies in the
differential diagnosis of small round cell soft tissue tumors. Arkhiv Patologii.
2004 Mar-Apr;66(2):31-36.
4. Armand R, Cappola AR, Horenstein RB, Drachenberg CB, Sasano H,
Papadimitriou JC. Adrenal cortical adenoma with excess black pigment
deposition, combined with myelolipoma and clinical Cushing’s syndrome.
International Journal of Surgical Pathology. 2004 Jan;12(1):57-61.
5. Armand R, Hess JR. Treating coagulopathy in trauma patients. Transfusion
Medicine Reviews. 2003 Jul;17(3):223-31.
6. Armand R, Brenner DS, Sun CC. Pathologic quiz case; fetal death at 32 weeks of
gestation. Archives of Pathology and Laboratory Medicine. 2003 Jul;127(7):e317-
18.
7. Shen J, Khan N, Lewis LD, Armand R, Grinberg O, Demidenko E, Swartz H.
Oxygen Consumption Rates and Oxygen Concentration in Molt-4 Cells and Their
mtDNA Depleted (rho(0)) Mutants. Biophysical Journal. 2003 Feb;84(2):1291-8.
Abstracts
1. Olszanski AJ, LaCroix-Fralish ML, Armand R, Perez RP, Lewis LD. Molt-4
rho(0) cells upregulate stress-induced survival genes in an attempt to overcome
the potentially lethal consequence of mitochondrial DNA depletion. American
Society for Clinical Pharmacology and Therapeutics. Annual meeting. 2004 Mar
24-27. Miami Beach, FL. Poster presentation.
2. Armand R, Duh SH, Hess JR. Simultaneous measurement of Erythrocyte ATP,
ADP, AMP, and 2,3-DPG by tandem mass spectrometry. American Society of
Hematology. Annual meeting. 2003 Dec 6-9. San Diego, CA. Poster presentation.
3. Armand R, Lewis LD, Kintner J, White K, Smith J, Perez RP. Genotypic and
phenotypic effects in Molt-4 cells chronically treated with Ethidium Bromide.
American Society for Clinical Pharmacology and Therapeutics. Annual meeting.
2003 Apr 2-5. Washington, DC. Poster presentation.
4. Armand R, Romain K, Henry MR. The prevalence and significance of the human
papillomavirus (HPV) cytopathic changes in the urine specimens of allograft
recipients. American Society of Cytopathology. Annual scientific meeting. 2002
Nov 5-9. Salt Lake City, UT. Poster presentation.
References
Farinaz Arbab, M.D., Pathologist
West Houston Medical Center
12141 Richmond Ave.
Houston, TX 77082
Phone: 281-***-****
*******.*****@************.***
Jerzy Morkowski, M.D., Pathologist
MLD Pathology
1140 Business Center Dr., Ste. 370
Houston, TX 77043
Phone: 713-***-****
*****.*********@************.***
LaBaron Washington, M.D., Hematopathologist
Houston Northwest Medical Center
710 FM 1960 Rd West, Ste. C
Houston, TX 77090
Phone: 281-***-****
*******@*******.***